Sebela Pharmaceuticals

Sebela Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of prescription products in Gastroenterology, Women's Health, and Dermatology. The company operates with a dual-hub model, with corporate headquarters in Roswell, Georgia, and a major research, development, and manufacturing center in Braintree, Massachusetts (operating as Braintree Laboratories). Sebela has established a market-leading position in the gastroenterology space, particularly in colonoscopy preparation, though it recently divested its bowel prep franchise to focus on novel therapeutics. The company is currently advancing a late-stage pipeline that includes a novel potassium-competitive acid blocker (P-CAB) for GERD and innovative long-acting reversible contraceptives (LARC) in its Women's Health division.